Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Korea And U.S. Health Ministers Agree To Enhance Cooperation In Anticipation Of Increased Pharma, Device Trade

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Korea and the U.S. have agreed to strengthen their relationship in the healthcare sector through personnel and information exchanges on food and drug regulations, but an official at South Korea's Ministry of Health and Welfare denied Korean media reports that the countries formalized the agreement with a memorandum of understanding

You may also be interested in...



Korea Health Ministry Mulling Expansion Of OTC Drug Sales: Will Korea Follow The Japan Model?

SEOUL - South Korea's Ministry of Health and Welfare is now working on a healthcare package aimed at allowing sales of some over-the-counter drugs at supermarkets and convenience shops, an effort that would expand OTC sales beyond traditional pharmacy outlets

Korea Health Ministry Mulling Expansion Of OTC Drug Sales: Will Korea Follow The Japan Model?

SEOUL - South Korea's Ministry of Health and Welfare is now working on a healthcare package aimed at allowing sales of some over-the-counter drugs at supermarkets and convenience shops, an effort that would expand OTC sales beyond traditional pharmacy outlets

Merck Signs Wide-Ranging MOU To Help Beef Up Korea's Global R&D Capabilities

SEOUL - Merck & Co. Inc. has signed a memorandum of understanding with South Korea to invest KRW 210 billion ($192.9 million) in the country for research and development of new drugs, including manpower exchanges, Korea's Ministry of Health and Welfare said

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

SC077553

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel